Since 2015, major efforts have been made to accelerate the uptake of digital adherence technologies (DATs) for people-centered tuberculosis (TB) care and treatment modalities.

To contribute to the further evaluation of DATs in line with the targets set forth in the Global Plan to End TB and the End TB Strategy, an optimal introduction and scale-up of DATs, and further innovation in DATs and supporting/enabling tools, processes and systems, a Global Digital Adherence Technologies Task Force ("DAT Task Force") has been established for an initial period of two years (July 2020-July 2022).

The DAT Task Force will consist of a broad spectrum of country and global partners and stakeholders, including people affected by TB, country policymakers, academia/researchers, donors/funders, implementing/technical partners, information and communication technology (ICT) experts, among others.

The coordinating body of this DAT Task Force will be the External Affairs & Strategic Initiatives (EASI) team at the Stop TB Partnership in Geneva, Switzerland, and will consist of six dedicated workstreams.

This webpage will be regularly updated with new information and materials to support country programmes, implementing partners, and civil society and communities in the optimal roll-out of DATs.

For any questions related to the below-mentioned content and resources and/or the roll-out of DATs, please contact

Workstream 1 - Evidence Generation

Materials to be added

Workstream 2 - Implementation

Planning and implementation of DATs - Tools and resources

ASCENT Project's Online implementation toolkit

Background information on DATs

Key steps to implement DATs

Training & capacity building on DATs

TB REACH's Concept note on DATs for Wave 6

Workstream 3 - Policy & Funding

Quick guide to video-supported treatment of tuberculosis (2020)

Handbook for the use of digital technologies to support tuberculosis medication adherence (2018)

Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017)

Technical guidance and budget for Global Fund funding request

Workstream 4 - Market Access

ASCENT Project's Total cost of ownership

Global Drug Facility's Product catalogue

Global Drug Facility's Product order form

Global Drug Facility's Technical information note on smart medication container kit

Workstream 5 - Technology Innovation & Process

Materials to be added

Workstream 6 - Advocacy, Communications & Demand Generation

EASI's Virtual Innovation Spotlight presentation on 99DOTs, smart pill box & VOT